がん治療薬の世界市場

がん治療薬の世界市場2023-2027

がん治療薬市場は2022-2027年に1,518億4,000万米ドル、予測期間中のCAGRは11.99％で成長すると予測されます。当レポートでは、がん治療薬市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界のがん罹患率の増加、創薬および市場開拓におけるコスト削減の必要性、がん予防に関する認識を広めるための政府や様々な非営利団体によるイニシアチブの高まりによって牽引されています。

本調査では、今後数年間のがん治療薬市場成長を牽引する主な要因の1つとして、免疫療法の採用が増加していることを挙げています。また、低侵襲外科手術に対する需要の高まり、バイオ医薬品業界における投資と市場開拓の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• がん治療薬の世界市場 2017-2021
• 治療分野の分析 2017-2021
• 流通チャネルセグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーションセラピー別

• 市場セグメント
• 比較セラピー別
• 標的療法：市場規模と予測 2022-2027
• 免疫療法とホルモン療法：市場規模と予測 2022-2027
• 化学療法：市場規模と予測 2022-2027
• 市場機会セラピー別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• オフライン：市場規模と予測 2022-2027
• オンライン：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 日本：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Amgen Inc.
• Aspen Pharmacare Holdings Ltd
• AstraZeneca
• Athenex Inc.
• Bayer AG
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Co. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global oncology drugs market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
• Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Therapy
• Exhibits33: Data Table on Comparison by Therapy
• Exhibits34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by Therapy ($ billion)
• Exhibits47: Data Table on Market opportunity by Therapy ($ billion)
• Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by Distribution Channel
• Exhibits51: Data Table on Comparison by Distribution Channel
• Exhibits52: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
• Exhibits53: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
• Exhibits54: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Online - Market size and forecast 2022-2027 ($ billion)
• Exhibits57: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
• Exhibits58: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Online - Year-over-year growth 2022-2027 (%)
• Exhibits60: Market opportunity by Distribution Channel ($ billion)
• Exhibits61: Data Table on Market opportunity by Distribution Channel ($ billion)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ billion)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits105: Impact of drivers and challenges in 2022 and 2027
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: AbbVie Inc. - Overview
• Exhibits112: AbbVie Inc. - Product / Service
• Exhibits113: AbbVie Inc. - Key news
• Exhibits114: AbbVie Inc. - Key offerings
• Exhibits115: Amgen Inc. - Overview
• Exhibits116: Amgen Inc. - Product / Service
• Exhibits117: Amgen Inc. - Key offerings
• Exhibits118: Aspen Pharmacare Holdings Ltd - Overview
• Exhibits119: Aspen Pharmacare Holdings Ltd - Business segments
• Exhibits120: Aspen Pharmacare Holdings Ltd - Key offerings
• Exhibits121: Aspen Pharmacare Holdings Ltd - Segment focus
• Exhibits122: AstraZeneca - Overview
• Exhibits123: AstraZeneca - Product / Service
• Exhibits124: AstraZeneca - Key news
• Exhibits125: AstraZeneca - Key offerings
• Exhibits126: Athenex Inc. - Overview
• Exhibits127: Athenex Inc. - Product / Service
• Exhibits128: Athenex Inc. - Key offerings
• Exhibits129: Bayer AG - Overview
• Exhibits130: Bayer AG - Business segments
• Exhibits131: Bayer AG - Key news
• Exhibits132: Bayer AG - Key offerings
• Exhibits133: Bayer AG - Segment focus
• Exhibits134: Bristol Myers Squibb Co. - Overview
• Exhibits135: Bristol Myers Squibb Co. - Product / Service
• Exhibits136: Bristol Myers Squibb Co. - Key news
• Exhibits137: Bristol Myers Squibb Co. - Key offerings
• Exhibits138: Eli Lilly and Co. - Overview
• Exhibits139: Eli Lilly and Co. - Product / Service
• Exhibits140: Eli Lilly and Co. - Key news
• Exhibits141: Eli Lilly and Co. - Key offerings
• Exhibits142: F. Hoffmann La Roche Ltd. - Overview
• Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits144: F. Hoffmann La Roche Ltd. - Key news
• Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits147: GlaxoSmithKline Plc - Overview
• Exhibits148: GlaxoSmithKline Plc - Business segments
• Exhibits149: GlaxoSmithKline Plc - Key news
• Exhibits150: GlaxoSmithKline Plc - Key offerings
• Exhibits151: GlaxoSmithKline Plc - Segment focus
• Exhibits152: Johnson and Johnson Services Inc. - Overview
• Exhibits153: Johnson and Johnson Services Inc. - Business segments
• Exhibits154: Johnson and Johnson Services Inc. - Key news
• Exhibits155: Johnson and Johnson Services Inc. - Key offerings
• Exhibits156: Johnson and Johnson Services Inc. - Segment focus
• Exhibits157: Novartis AG - Overview
• Exhibits158: Novartis AG - Business segments
• Exhibits159: Novartis AG - Key offerings
• Exhibits160: Novartis AG - Segment focus
• Exhibits161: Pfizer Inc. - Overview
• Exhibits162: Pfizer Inc. - Product / Service
• Exhibits163: Pfizer Inc. - Key news
• Exhibits164: Pfizer Inc. - Key offerings
• Exhibits165: Sanofi - Overview
• Exhibits166: Sanofi - Business segments
• Exhibits167: Sanofi - Key news
• Exhibits168: Sanofi - Key offerings
• Exhibits169: Sanofi - Segment focus
• Exhibits170: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits171: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits174: Inclusions checklist
• Exhibits175: Exclusions checklist
• Exhibits176: Currency conversion rates for US$
• Exhibits177: Research methodology
• Exhibits178: Validation techniques employed for market sizing
• Exhibits179: Information sources
• Exhibits180: List of abbreviations

Global Oncology Drugs Market 2023-2027

The oncology drugs market is forecasted to grow by USD 151.84 bn during 2022-2027, accelerating at a CAGR of 11.99% during the forecast period. The report on the oncology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of cancer globally, the need for cost-cutting in drug discovery and development, and rising initiatives by the government and various non-profit organizations to spread awareness regarding cancer prevention.

Technavio's oncology drugs market is segmented as below:

By Therapy

• Targeted therapy
• Immunotherapy
• Hormonal therapy
• Chemotherapy

By Distribution Channel

• Offline
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising adoption of immunotherapy as one of the prime reasons driving the oncology drugs market growth during the next few years. Also, growing demand for minimally invasive surgical procedures and rising investments and developments in the biopharmaceutical industry will lead to sizable demand in the market.

The report on the oncology drugs market covers the following areas:

• Oncology drugs market sizing
• Oncology drugs market forecast
• Oncology drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology drugs market vendors that include AbbVie Inc., Amgen Inc., Apikos Pharma, Arlak Biotech Pvt. Ltd., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., AstraZeneca, Athenex Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Kremedine Health Pvt Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., and Bristol Myers Squibb Co.. Also, the oncology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global oncology drugs market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global oncology drugs market 2017 - 2021 ($ billion)
• 4.2 Therapy Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ billion)
• 4.3 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy

• 6.1 Market segments
• Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
• 6.2 Comparison by Therapy
• Exhibit 32: Chart on Comparison by Therapy
• Exhibit 33: Data Table on Comparison by Therapy
• 6.3 Targeted therapy - Market size and forecast 2022-2027
• Exhibit 34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
• 6.4 Immunotherapy and hormonal therapy - Market size and forecast 2022-2027
• Exhibit 38: Chart on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
• 6.5 Chemotherapy - Market size and forecast 2022-2027
• Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by Therapy
• Exhibit 46: Market opportunity by Therapy ($ billion)
• Exhibit 47: Data Table on Market opportunity by Therapy ($ billion)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 50: Chart on Comparison by Distribution Channel
• Exhibit 51: Data Table on Comparison by Distribution Channel
• 7.3 Offline - Market size and forecast 2022-2027
• Exhibit 52: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
• Exhibit 54: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• 7.4 Online - Market size and forecast 2022-2027
• Exhibit 56: Chart on Online - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
• Exhibit 58: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Online - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Distribution Channel
• Exhibit 60: Market opportunity by Distribution Channel ($ billion)
• Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 China - Market size and forecast 2022-2027
• Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.9 Japan - Market size and forecast 2022-2027
• Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.10 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 111: AbbVie Inc. - Overview
• Exhibit 112: AbbVie Inc. - Product / Service
• Exhibit 113: AbbVie Inc. - Key news
• Exhibit 114: AbbVie Inc. - Key offerings
• 12.4 Amgen Inc.
• Exhibit 115: Amgen Inc. - Overview
• Exhibit 116: Amgen Inc. - Product / Service
• Exhibit 117: Amgen Inc. - Key offerings
• 12.5 Aspen Pharmacare Holdings Ltd
• Exhibit 118: Aspen Pharmacare Holdings Ltd - Overview
• Exhibit 119: Aspen Pharmacare Holdings Ltd - Business segments
• Exhibit 120: Aspen Pharmacare Holdings Ltd - Key offerings
• Exhibit 121: Aspen Pharmacare Holdings Ltd - Segment focus
• 12.6 AstraZeneca
• Exhibit 122: AstraZeneca - Overview
• Exhibit 123: AstraZeneca - Product / Service
• Exhibit 124: AstraZeneca - Key news
• Exhibit 125: AstraZeneca - Key offerings
• 12.7 Athenex Inc.
• Exhibit 126: Athenex Inc. - Overview
• Exhibit 127: Athenex Inc. - Product / Service
• Exhibit 128: Athenex Inc. - Key offerings
• 12.8 Bayer AG
• Exhibit 129: Bayer AG - Overview
• Exhibit 130: Bayer AG - Business segments
• Exhibit 131: Bayer AG - Key news
• Exhibit 132: Bayer AG - Key offerings
• Exhibit 133: Bayer AG - Segment focus
• 12.9 Bristol Myers Squibb Co.
• Exhibit 134: Bristol Myers Squibb Co. - Overview
• Exhibit 135: Bristol Myers Squibb Co. - Product / Service
• Exhibit 136: Bristol Myers Squibb Co. - Key news
• Exhibit 137: Bristol Myers Squibb Co. - Key offerings
• 12.10 Eli Lilly and Co.
• Exhibit 138: Eli Lilly and Co. - Overview
• Exhibit 139: Eli Lilly and Co. - Product / Service
• Exhibit 140: Eli Lilly and Co. - Key news
• Exhibit 141: Eli Lilly and Co. - Key offerings
• 12.11 F. Hoffmann La Roche Ltd.
• Exhibit 142: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 143: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 144: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 145: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 146: F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 GlaxoSmithKline Plc
• Exhibit 147: GlaxoSmithKline Plc - Overview
• Exhibit 148: GlaxoSmithKline Plc - Business segments
• Exhibit 149: GlaxoSmithKline Plc - Key news
• Exhibit 150: GlaxoSmithKline Plc - Key offerings
• Exhibit 151: GlaxoSmithKline Plc - Segment focus
• 12.13 Johnson and Johnson Services Inc.
• Exhibit 152: Johnson and Johnson Services Inc. - Overview
• Exhibit 153: Johnson and Johnson Services Inc. - Business segments
• Exhibit 154: Johnson and Johnson Services Inc. - Key news
• Exhibit 155: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 156: Johnson and Johnson Services Inc. - Segment focus
• 12.14 Novartis AG
• Exhibit 157: Novartis AG - Overview
• Exhibit 158: Novartis AG - Business segments
• Exhibit 159: Novartis AG - Key offerings
• Exhibit 160: Novartis AG - Segment focus
• 12.15 Pfizer Inc.
• Exhibit 161: Pfizer Inc. - Overview
• Exhibit 162: Pfizer Inc. - Product / Service
• Exhibit 163: Pfizer Inc. - Key news
• Exhibit 164: Pfizer Inc. - Key offerings
• 12.16 Sanofi
• Exhibit 165: Sanofi - Overview
• Exhibit 166: Sanofi - Business segments
• Exhibit 167: Sanofi - Key news
• Exhibit 168: Sanofi - Key offerings
• Exhibit 169: Sanofi - Segment focus
• 12.17 Takeda Pharmaceutical Co. Ltd.
• Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 174: Inclusions checklist
• Exhibit 175: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 176: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 177: Research methodology
• Exhibit 178: Validation techniques employed for market sizing
• Exhibit 179: Information sources
• 13.5 List of abbreviations
• Exhibit 180: List of abbreviations